Literature DB >> 15284465

Intraoperative sonography of intracranial arteriovenous malformations: how we do it.

Sara Griffith1, Myron A Pozniak, Carol C Mitchell, Michael E Ledwidge, Robert Dempsey, Amy Peters, Erin Taylor.   

Abstract

OBJECTIVE: We have advanced the application of intraoperative neurosonography by combining gray scale sonographic imaging with pulsed wave Doppler and color flow Doppler imaging to guide and confirm resection of arteriovenous malformations of the brain. We want to share our technique with the imaging community.
METHODS: We present a review of our scan technique as it has evolved over the 3 years during which we have been assisting our neurosurgical team. RESULTS AND
CONCLUSIONS: Our experience has indicated that a combination of sonographic imaging and color and spectral Doppler imaging improves surgical resection of such lesions.

Entities:  

Mesh:

Year:  2004        PMID: 15284465     DOI: 10.7863/jum.2004.23.8.1065

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  3 in total

Review 1.  The application of ultrasound in the management of cerebral arteriovenous malformation.

Authors:  Bing Fu; Ji-Zong Zhao; Lan-Bing Yu
Journal:  Neurosci Bull       Date:  2008-12       Impact factor: 5.203

2.  Real-time intraoperative ultrasonography in the surgical resection of brain lesions: A cheap, effective, and quick alternative.

Authors:  Pk Upadhyay; G Tiwary
Journal:  J Neurosci Rural Pract       Date:  2010-07

Review 3.  Chinese Cerebrovascular Neurosurgery Society and Chinese Interventional & Hybrid Operation Society, of Chinese Stroke Association Clinical Practice Guidelines for Management of Brain Arteriovenous Malformations in Eloquent Areas.

Authors:  Mingze Wang; Yuming Jiao; Chaofan Zeng; Chaoqi Zhang; Qiheng He; Yi Yang; Wenjun Tu; Hancheng Qiu; Huaizhang Shi; Dong Zhang; Dezhi Kang; Shuo Wang; A-Li Liu; Weijian Jiang; Yong Cao; Jizong Zhao
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.